Skip to main content

Table 3 This table shows the serum hormonal characteristics of the cases and controls.

From: Evaluation of early atherosclerotic findings in women with polycystic ovary syndrome

Variable Groups Number Mean ± SD P Value
FSH (mIu/ml) Controls 45 5.57 ± 1.88 0.01
  Cases 46 7.33 ± 4.25  
LH (mIu/ml) Controls 45 5.46 ± 4.72 0.24
  Cases 46 26.51 ± 14.63  
PRL (ng/ml) Controls 45 13.61 ± 5.39 0.001
  Cases 46 21.15 ± 19.11  
Testosterone Controls 45 0.55 ± 0.87 0.001
  Cases 46 1.58 ± 1.21  
DHEAS (g/dl μ) Controls 45 187.22 ± 105.61 0.001
  Cases 46 284.48 ± 111.18  
17(OH) Progesterone (ng/dl) Controls 45 1.25 ± 0.76 0.23
  Cases 46 1.69 ± 2.35  
Insulin (mIu/ml) Controls 45 4.34 ± 1.90 0.001
  Cases 46 12.62 ± 8.13